BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Signal Genetics LLC 

667 Madison Avenue
14th Floor
New York  New York  10065  U.S.A.
Phone: 212-486-0040 Fax: 212-319-3328


SEARCH JOBS




Industry
Diagnostics






 Company News
Signal Genetics LLC (SGNL) Appoints Michael C. Cerio Senior Vice President Of Commercial Strategy And Business Development 8/11/2014 8:10:12 AM
Signal Genetics LLC (SGNL) Obtains New York State Approval For MyPRS® Multiple Myeloma Prognostic Test 6/30/2014 12:05:54 PM
Signal Genetics LLC (SGNL) Announces Closing Of Initial Public Offering Of 850,000 Shares Of Common Stock 6/24/2014 8:32:36 AM
New York's Signal Genetics LLC (SGNL) Prices IPO At $10 A Share 6/18/2014 7:40:38 AM
Med BioGene Announces Settlement Agreement for the Dismissal of Litigation With Signal Genetics LLC and Respira Health LLC 8/22/2013 7:07:06 AM
Med BioGene Update to Ongoing Signal Genetics LLC and Respira Lawsuit 2/25/2013 8:04:39 AM
Signal Genetics LLC to Buy ChipDX LLC to Gain Cancer Diagnostics 2/2/2012 10:35:19 AM
Signal Genetics LLC Announces Publication of Meta-Analysis of its Colon Cancer Test-Previstage(TM) GCC Confirming Prognostic Capabilities in Patients with Colon Cancer 1/24/2012 9:20:59 AM
Signal Genetics LLC Announces Launch of Next Generation Genetic Multiple Myeloma Predictive Testing Product-MyPRS Plus(TM) 12/9/2011 10:45:21 AM
Signal Genetics LLC and DiagnoCure (CUR) Announce a US $13.3 Million Collaboration for the Commercialization of Previstage(TM) GCC Colorectal Cancer Staging Test 6/29/2011 7:01:02 AM
12